Linked Data API

Show Search Form

Search Results

1149333
registered interest false more like this
date less than 2019-10-15more like thismore than 2019-10-15
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care remove filter
hansard heading Epilepsy: Drugs more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, whether anti-epileptic drugs are exempted from serious shortage protocols; and what assessment he has made of the potential effect of the use of such protocols on (a) people with learning disabilities and (b) their families in the event that the UK leaves the EU without a withdrawal agreement. more like this
tabling member constituency North Norfolk more like this
tabling member printed
Norman Lamb remove filter
uin 475 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-10-21more like thismore than 2019-10-21
answer text <p>While Serious Shortage Protocols (SSP) in England have the scope to cover all medicines and appliances that are on a National Health Service prescription in primary care, including anti-epileptic drugs, it is clear that an SSP for therapeutic or generic equivalents will not necessarily be suitable for all medicines and patients. For example, where medicines need to be prescribed by brand for clinical reasons, which is the case for epilepsy medication.</p><p>Any protocol would only be introduced if clinicians with expertise in the relevant area think it is appropriate. Pharmacists will have to use their professional judgment as to whether supplying against the protocol rather than the prescription is appropriate or the patient should be referred to their prescriber.</p><p>The legislation enabling Ministers to issue SSPs was not introduced as a European Union exit measure alone but as a business-as-usual measure that can be used before and after our exit from the EU.</p> more like this
answering member constituency Charnwood more like this
answering member printed Edward Argar more like this
question first answered
less than 2019-10-21T13:07:33.52Zmore like thismore than 2019-10-21T13:07:33.52Z
answering member
4362
label Biography information for Edward Argar more like this
tabling member
1439
label Biography information for Norman Lamb more like this